ACIU vs BANB: Side-by-Side Comparison
Compare AC Immune SA (ACIU) and Bachem Holding AG (BANB) side by side: market cap USD 255.45M vs CHF 5.67B. Financials, growth and model signals on Bullrun.
| Metric | ACIU | BANB |
|---|---|---|
| Company | AC Immune SA | Bachem Holding AG |
| Country / Exchange | Switzerland · NASDAQ | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 255.45M | CHF 5.67B |
| P/E ratio | — | 38.2 |
| Dividend yield | — | 1.23% |
| Valuation model | — | — |
| Revenue (latest FY) | — | CHF 695.07M |
| Revenue growth YoY | — | +14.8% |
| Net income | — | CHF 148.79M |
| Gross margin | — | 28.7% |
| Diluted EPS | — | 1.98 |